Suppr超能文献

经颈静脉肝内门体分流术在改善失代偿期肝病患者生存率方面的作用。

Role of TIPS in Improving Survival of Patients with Decompensated Liver Disease.

作者信息

Punamiya Sundeep J, Amarapurkar Deepak N

机构信息

Department of Radiology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433.

出版信息

Int J Hepatol. 2011;2011:398291. doi: 10.4061/2011/398291. Epub 2011 Jul 2.

Abstract

Liver cirrhosis is associated with higher morbidity and reduced survival with appearance of portal hypertension and resultant decompensation. Portal decompression plays a key role in improving survival in these patients. Transjugular intrahepatic portosystemic shunts are known to be efficacious in reducing portal venous pressure and control of complications such as variceal bleeding and ascites. However, they have been associated with significant problems such as poor shunt durability, increased encephalopathy, and unchanged survival when compared with conservative treatment options. The last decade has seen a significant improvement in these complications, with introduction of covered stents, better selection of patients, and clearer understanding of procedural end-points. Use of TIPS early in the period of decompensation also appears promising in further improvement of survival of cirrhotic patients.

摘要

肝硬化与较高的发病率以及门静脉高压出现后导致失代偿从而降低生存率相关。门体分流减压在改善这些患者的生存率方面起着关键作用。经颈静脉肝内门体分流术在降低门静脉压力以及控制诸如静脉曲张出血和腹水等并发症方面已知是有效的。然而,与保守治疗方案相比,它们存在诸如分流耐久性差、肝性脑病增加以及生存率未改变等重大问题。在过去十年中,随着覆膜支架的引入、更好的患者选择以及对手术终点更清晰的认识,这些并发症有了显著改善。在失代偿期早期使用经颈静脉肝内门体分流术在进一步提高肝硬化患者的生存率方面似乎也很有前景。

相似文献

1
Role of TIPS in Improving Survival of Patients with Decompensated Liver Disease.
Int J Hepatol. 2011;2011:398291. doi: 10.4061/2011/398291. Epub 2011 Jul 2.
3
Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.
World J Gastroenterol. 2014 Dec 7;20(45):16996-7010. doi: 10.3748/wjg.v20.i45.16996.
5
Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.
World J Gastroenterol. 2020 Oct 7;26(37):5561-5596. doi: 10.3748/wjg.v26.i37.5561.
7
Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.
Lancet Gastroenterol Hepatol. 2019 Aug;4(8):587-598. doi: 10.1016/S2468-1253(19)30090-1. Epub 2019 May 29.
9
The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S344-51. doi: 10.1097/MCG.0b013e318157e500.

引用本文的文献

1
Outpatient management after hospitalisation for acute decompensation of cirrhosis: A practical guide.
World J Hepatol. 2024 Dec 27;16(12):1377-1394. doi: 10.4254/wjh.v16.i12.1377.
3
Case Control Study of Post-endoscopic Variceal Ligation Bleeding Ulcers in Severe Liver Disease: Outcomes and Management.
J Clin Transl Hepatol. 2019 Mar 28;7(1):32-39. doi: 10.14218/JCTH.2018.00059. Epub 2019 Mar 10.
5
Risk factors for frequent readmissions and barriers to transplantation in patients with cirrhosis.
PLoS One. 2013;8(1):e55140. doi: 10.1371/journal.pone.0055140. Epub 2013 Jan 28.
7
Role of self-expandable metal stents in acute variceal bleeding.
Int J Hepatol. 2012;2012:418369. doi: 10.1155/2012/418369. Epub 2012 Aug 9.

本文引用的文献

3
Early use of TIPS in patients with cirrhosis and variceal bleeding.
N Engl J Med. 2010 Jun 24;362(25):2370-9. doi: 10.1056/NEJMoa0910102.
5
Causes of TIPS dysfunction.
AJR Am J Roentgenol. 2008 Dec;191(6):1751-7. doi: 10.2214/AJR.07.3534.
9
Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents.
Eur J Gastroenterol Hepatol. 2006 Mar;18(3):225-32. doi: 10.1097/00042737-200603000-00001.
10
Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.
J Hepatol. 2006 Jan;44(1):217-31. doi: 10.1016/j.jhep.2005.10.013. Epub 2005 Nov 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验